WHO ICTRP trial

A phase III assessor-blinded randomised parallel group multi-centre study to…

EUCTR2010-019287-37-DE · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2010-019287-37-DE
Public title A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment - not available
Scientific title A phase III assessor-blinded randomised parallel group multi-centre study to compare efficacy adn safety of two r-hFSH formulations (AFOLIA and Gonal-f®) in women for assisted reproductive treatment - not available
Primary sponsor Finox AG
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no
Countries Spain;Denmark;Austria;Germany;United Kingdom
Conditions Stimulation of multifollicular develoment in patients undergoing assisted reproductivet treatment
Interventions Product Name: AFOLIA Product Code: not applicable Pharmaceutical Form: Solution for injection INN or Proposed INN: Follitropin alfa CAS Number: n.a. Current Sponsor code: human follicle stimulating hormone Other descriptive name: n.a…
Registration date Apr 22, 2010
Target size 393
Secondary IDs FIN3001;not available
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations